Faze Medicines
Financing Rounds
- Series A
- Exit
Round Led by Symbiosis
Round Led by Symbiosis
Biomolecular condensates are dynamic clusters which contain proteins and nucleic acids within a cell. Groundbreaking research by Faze’s co-founder J. Paul Taylor has demonstrated that condensates are at the root of many related neurological diseases, such as ALS, frontotemporal dementia, and inclusion body myositis. Faze Medicines is harnessing this groundbreaking new science to create medical breakthroughs.
Modality
- Small Molecule
Indication
- Neurology
Development Status
- Pre-Clinical